Inventor · disambiguated record
Daniel W. Robbins
Also filed as: ROBBINS DANIEL · ROBBINS DANIEL W
6 granted patents·4 pending applications·23 citations·filing 2012–2022
79Inventor score
Top patents by PatentIndex Score
10 records- 0194US11866442B2Bifunctional compounds for degrading BTK via ubiquitin proteosome pathwayNURIX THERAPEUTICS INC·Filed 2022·Granted Jan 9, 2024·5 cites·37 claims
- 0293US11479556B1Bifunctional compounds for degrading BTK via ubiquitin proteosome pathwayNURIX THERAPEUTICS INC·Filed 2019·Granted Oct 25, 2022·9 cites·106 claims
- 0389US9840518B2MCL-1 inhibitors and methods of use thereofASTRAZENECA AB·Filed 2017·Granted Dec 12, 2017·9 cites·4 claims
- 0469US11472816B2Mcl-1 inhibitors and methods of use thereofASTRAZENECA AB·Filed 2020·Granted Oct 18, 2022·0 cites·9 claims
- 0567US10889594B2MCL-1 inhibitors and methods of use thereofASTRAZENECA AB·Filed 2018·Granted Jan 12, 2021·0 cites·10 claims
- 0659US10196404B2MCL-1 inhibitors and methods of use thereofASTRAZENECA AB·Filed 2017·Granted Feb 5, 2019·0 cites·4 claims
- 0756US2025002489A1Bifunctional compounds for degrading itk via ubiquitin proteosome pathwayNURIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0850US2022324835A1Inhibitors of cbl-b and methods of use thereofNURIX THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0944US2023024442A1Bifunctional compounds for grading btk via ubiquitin proteosome pathwayNURIX THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1035US2013274144A1Compounds, reactions, and screening methodsHARTWIG JOHN F·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daniel W. Robbins files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →